ITIF Logo
ITIF Search

Testimonies & Filings

Advising Policymakers

ITIF provides policy expertise to governments around the world, frequently testifying and filing public comments for official hearings, inquiries, and regulatory proceedings.

March 20, 2025

Memo to the U.S. Treasury Department Regarding President Trump’s America First Trade Policy

The administration should address concerns related to counterfeit products, discriminatory digital taxes, and investment controls for critical technologies with measures to protect American innovation while promoting fair, rules-based trade principles that benefit the U.S. economy and support U.S. technological leadership.

March 20, 2025

Memo to the U.S. Commerce Department Regarding President Trump’s America First Trade Policy

The administration should address mercantilist policies that systematically disadvantage American businesses and workers with corrective measures such as strategic enforcement actions, reciprocal tariffs, expanded trade agreements, and stronger digital trade protections.

March 20, 2025

Memo to the U.S. Trade Representative Regarding President Trump’s America First Trade Policy

The administration should address trade imbalances, discriminatory regulations, and digital trade restrictions imposed by China, India, and the European Union, among others. Targeted policy responses may include reciprocal tariffs, digital trade enforcement, fair pricing mechanisms, and strengthened trade agreements to ensure a level playing field for U.S. businesses.

March 14, 2025

Comments to the Office of Science and Technology Policy on the Development of an AI Action Plan

The Center for Data Innovation outlined seven policy priorities we believe to be most critical for the AI Action Plan, along with specific actions the administration should take.

February 27, 2025

Comments to CMS on the List of Drugs for Price Setting Starting in 2027

Recent policies permitting CMS price setting are hamstringing the U.S. biopharmaceutical industry, as they reduce incentives for pharmaceutical companies to invest in future drug R&D to create life-improving and life-saving medicines.

February 26, 2025

Comments to the Australian Treasury Regarding Proposal of a New Digital Competition Regime

By deciding not to pursue digital competition regulation, Australia can avoid the problems that are already materializing as a result of ex-ante regimes like the EU’s DMA.

February 25, 2025

Comments to the UK Government on Proposed Changes to the Copyright, Design, and Patents Act 1988

The Center for Data Innovation submitted these comments to the UK government’s Intellectual Property Office, Department for Science, Innovation and Technology, and Department for Culture, Media and Sport on its consultation on proposed changes to the UK’s copyright regime, the Copyright, Design, and Patents Act (CDPA) 1988.

February 21, 2025

Comments to the California Privacy Protection Agency’s Proposed AI Regulations

The California Privacy Protection Agency (CPPA) has proposed regulations that would impose new requirements on businesses using automated decision-making technology.

February 7, 2025

Comments to New Zealand’s Ministry of Business, Innovation and Employment Regarding Review of the Commerce Act of 1986

While ITIF commends the MBIE for analyzing the efficacy of its current regime, substantial changes to New Zealand’s competition laws should be a response to clear market failures that improves consumer welfare, and not merely an attempt to keep up with perceived global or regional trends.

January 24, 2025

Comments to Standards Australia Regarding Children’s Safety in the Metaverse

Standards Australia should establish age-based guidelines for the metaverse using existing content ratings; require device operating systems to create an opt-in “trustworthy child flag” system; work with global, government-led groups to build voluntary industry standards with a focus on interoperability; and promote digital literacy campaigns for children to operate in the metaverse safely.

Back to Top